2004
DOI: 10.1001/archinte.164.13.1405
|View full text |Cite|
|
Sign up to set email alerts
|

Management of Alcohol Withdrawal Delirium<subtitle>An Evidence-Based Practice Guideline</subtitle>

Abstract: Control of agitation should be achieved using parenteral rapid-acting sedative-hypnotic agents that are cross-tolerant with alcohol. Adequate doses should be used to maintain light somnolence for the duration of delirium. Coupled with comprehensive supportive medical care, this approach is highly effective in preventing morbidity and mortality.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
202
0
16

Year Published

2005
2005
2014
2014

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 381 publications
(219 citation statements)
references
References 56 publications
1
202
0
16
Order By: Relevance
“…One important component of these guidelines is the use of escalating individual doses of benzodiazepines beyond currently recommended diazepam boluses of 10-30 mg (6). There are many reports of severe AWS and delirium tremens resistant to standard bolus doses of diazepam (9 -12, 20).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…One important component of these guidelines is the use of escalating individual doses of benzodiazepines beyond currently recommended diazepam boluses of 10-30 mg (6). There are many reports of severe AWS and delirium tremens resistant to standard bolus doses of diazepam (9 -12, 20).…”
Section: Discussionmentioning
confidence: 99%
“…Multiple studies suggest that administration of benzodiazepines in a symptom-triggered fashion both reduces the total amount of benzodiazepine administered and shortens the duration of therapy (4,5). In these studies, benzodiazepines are administered in repeated boluses (both intravenous and oral) of 10-20 mg of diazepam (or benzodiazepine equivalent) with current recommendations suggesting a maximal individual bolus of 20-30 mg of diazepam or benzodiazepine equivalent to be given until adequate sedation is achieved (4,6,7). Although widely accepted, these studies focus primarily on patients admitted to detoxification centers or the general hospital wards and exclude subjects admitted to the intensive care unit (ICU) (4,5).…”
mentioning
confidence: 99%
“…1,7,9 Clinicians differ in how well they adhere to these criteria, so it is difficult to determine the prevalence of withdrawal delirium, and rates depend on whether persons with this condition were treated as outpatients, as general medical or psychiatric inpatients, or as patients in an intensive care unit (ICU). Most studies estimate that 3 to 5% of patients who are hospitalized for alcohol withdrawal meet the criteria for withdrawal delirium.…”
Section: Withdrawal Delirium (Delirium Tremens)mentioning
confidence: 99%
“…7,9,12 Approximately 1 to 4% of hospitalized patients who have withdrawal delirium die; this rate could be reduced if an appropriate and timely diagnosis were made and symptoms were adequately treated. 7,9,11,13 Death usually results from hyperthermia, cardiac arrhythmias, complications of withdrawal seizures, or concomitant medical disorders.…”
Section: Withdrawal Delirium (Delirium Tremens)mentioning
confidence: 99%
“…The evidence on how best to treat alcohol withdrawal seizures comes from a 1999 article which demonstrated a benefit of using lorazepam for recurrent seizures. 19,20 21 All of these studies, however, come back to the basic question: Do they apply to the inpatients that hospitalists care for? A key factor to consider: All of the above-mentioned studies, including the derivation and validation of the CIWA scale, were done in outpatient centers or inpatient detoxification centers.…”
mentioning
confidence: 99%